Standard BioTools Inc.

NASDAQ: FLDM · Real-Time Price · USD
3.71
-0.28 (-7.02%)
At close: Apr 06, 2022, 6:00 AM

Standard BioTools Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2021
Period Ending Dec 31, 2021
Revenue
130.58M
Cost of Revenue
61.21M
Gross Profit
69.37M
Operating Income
-59.84M
Interest Income
n/a
Pretax Income
-63.66M
Net Income
-59.24M
Selling & General & Admin
98.89M
Research & Development
37.94M
Other Expenses
n/a
Operating Expenses
136.83M
Interest Expense
3.82M
Selling & Marketing Expenses
n/a
Cost & Expenses
198.04M
Income Tax Expense
-4.42M
Shares Outstanding (Basic)
76.3M
Shares Outstanding (Diluted)
76.3M
EPS (Basic)
-0.78
EPS (Diluted)
-0.78
EBITDA
-44.27M
EBIT
-59.84M
Depreciation & Amortization
15.57M